Capillary Hemangioma of the Retina and von Hippel–Lindau Disease

Hinz, Brad J.; Schachat, Andrew P.

doi:10.1016/b978-0-323-02598-0.50030-6

Cited by 5 publications

(3 citation statements)

References 82 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Singh et al [22] reported that with capillary hemangioma alone, the probability of being later diagnosed with VHL was 25%. Therefore, patients with RCH should be screened regularly for systemic abnormalities outside the eye [23]. Most RCHs progressively increase in size, and an increase in subretinal fluid can produce total retinal detachment and hemorrhage in the vitreous, retina, or subretinal space, resulting in decreased visual acuity [7].…”

Section: Discussionmentioning

confidence: 99%

Clinical Results of Various Treatments for Retinal Capillary Hemangioma

Won

Lee

Shin

et al. 2020

Korean J Ophthalmol

View full text Add to dashboard Cite

We report the clinical outcomes of retinal capillary hemangioma (RCH) after the application of various treatments. Methods: We performed a retrospective chart analysis of eight eyes treated for RCH between August 2009 and January 2018. During the follow-up period, the status and progression of the RCHs were checked by fundus photography, fluorescein angiography, and optical coherence tomography, and additional treatments were applied when necessary. Results: Three of the five patients had bilateral RCH, and two had unilateral RCH. Six eyes received laser photocoagulation; two eyes received cryotherapy, and one eye received intravitreal Avastin injection. Three eyes each had intravitreal triamcinolone injection, subtenon triamcinolone injection, and intravitreal dexamethasone injection to control inflammation. Also, two patients took oral prednisolone, and one patient used prednisolone eye drops to control inflammation. Two eyes underwent vitrectomy and scleral buckling due to deterioration of the epiretinal membrane (ERM) and vitreal traction, respectively. As a result of those treatments, the tumors were stable in five of the eight eyes. However, one eye is now in a pre-phthisis state, and one patient who refused treatment showed progression of the tumor, ERM, and traction. Conclusions: Because RCHs vary in size, the degree of inflammation, and symptoms, this disorder should be actively treated on a case-by-case basis. Fluorescein angiography should be used periodically to determine recurrence of the tumor or inflammation, and the appropriate treatment should be repeated as necessary. Moreover, regular systemic screening tests for von Hippel-Lindau disease should be performed in RCH patients to ensure that they have no abnormalities other than in the eye.

show abstract

Section: Discussionmentioning

confidence: 99%

Clinical Results of Various Treatments for Retinal Capillary Hemangioma

Won

Lee

Shin

et al. 2020

Korean J Ophthalmol

View full text Add to dashboard Cite

show abstract

“…Visual loss is primarily caused by exudative retinal detachment, which can be managed with treatments such as laser therapy, cryotherapy, and scleral buckling. 20…”

Section: Retinal Capillary Hemangiomamentioning

confidence: 99%

Pediatric ocular tumors: An overview

Raj,

Sahu

2024

IJOOO

View full text Add to dashboard Cite

The majority of ocular tumors in children are benign, but specific malignant neoplasms pose a risk to both life and vision. It's indeed crucial for pediatricians to be aware of ocular tumors in children, as early detection and proper management can significantly impact the child's health and vision. As a result, swift recognition and timely referral of patients to an ocular oncologist are imperative for effective clinical management. This article provides an overview of general concepts surrounding ocular tumors in the pediatric age group, offering brief insights into the clinical features and management of significant tumors affecting the eyelids, conjunctiva, intraocular structures, and orbit.

show abstract

“…Diferindo de outras facomatoses, as manifestações cutâneas são raras em VHL. Outras manifestações de VHL que podem chamar atenção do oftalmologista incluem retinopatia hipertensiva devido a feocromocitoma, hamartoma vascular da retina, síndrome quiasmática, defeito pupilar aferente devido a hemangioblastoma do nervo óptico (NO) e papiledema por lesões do SNC ou do nervo óptico (3) . O hemangioma capilar da retina (HCR) é a manifestação mais precoce da doença de VHL e usualmente não está presente ao nascimento.…”

Section: Introductionunclassified

Importância do exame oftalmológico na doença de von Hippel-Lindau

Aragão¹,

Barreira²,

Bezerra³

et al. 2009

Rev. bras.oftalmol.

View full text Add to dashboard Cite

RESUMOVon Hippel-Lindau (VHL) é uma síndrome tumoral autossômica dominante. Esses tumores incluem hemangioblastoma da retina e sistema nervoso central (CSN), carcinoma de células renais, feocromocitoma, tumores de pâncreas, cistoadenoma de rins, pâncreas e epidídimo. Os sintomas mais comuns são perda da visão, aumento da pressão intracraniana, déficits neurológicos, aumento da pressão arterial sistêmica paradoxal e dor local. Relatamos o caso de um paciente com perda de visão e história de hemangiomas cerebelares cujo diagnóstico de VHL foi feito após exame oftalmológico.

show abstract

Capillary Hemangioma of the Retina and von Hippel–Lindau Disease

Cited by 5 publications

References 82 publications

Clinical Results of Various Treatments for Retinal Capillary Hemangioma

Clinical Results of Various Treatments for Retinal Capillary Hemangioma

Pediatric ocular tumors: An overview

Importância do exame oftalmológico na doença de von Hippel-Lindau

Contact Info

Product

Resources

About